HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metachromatic Leukodystrophy due to Saposin B Deficiency

Also Known As:
Metachromatic Leukodystrophy due to Cerebroside Sulfatase Activator Deficiency; Saposin B Deficiency
Networked: 8 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1. Metachromatic Leukodystrophy (Sulfatide Lipidosis)
2. Combined Saposin Deficiency

Experts

1. Grabowski, Gregory A: 2 articles (07/2013 - 06/2013)
2. Sun, Ying: 2 articles (07/2013 - 06/2013)
3. Burin, Maira: 1 article (01/2020)
4. Conboy, Erin: 1 article (01/2020)
5. Gavrilov, Dimitar: 1 article (01/2020)
6. Giugliani, Roberto: 1 article (01/2020)
7. Lacey, Jean: 1 article (01/2020)
8. Matern, Dietrich: 1 article (01/2020)
9. Minnich, Sara: 1 article (01/2020)
10. Nickander, Kim: 1 article (01/2020)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Metachromatic Leukodystrophy due to Saposin B Deficiency:
1. SaposinsIBA
2. Sulfoglycosphingolipids (Sulfatides)IBA
3. Cerebroside-Sulfatase (Arylsulfatase A)IBA
4. Sphingolipid Activator ProteinsIBA
5. Biomarkers (Surrogate Marker)IBA
6. SphingolipidsIBA
7. Proteins (Proteins, Gene)FDA Link
8. LipidsIBA
9. Galactosylceramides (Galactocerebrosides)IBA
10. EnzymesIBA

Therapies and Procedures

1. Bone Marrow Transplantation (Transplantation, Bone Marrow)